About this Journal Submit a Manuscript Table of Contents
Case Reports in Obstetrics and Gynecology
Volume 2012 (2012), Article ID 687510, 5 pages
http://dx.doi.org/10.1155/2012/687510
Case Report

A Case of Endometrial Stromal Sarcoma with Synchronous Bilateral Adenocarcinoma of Ovary

1Gynecology and Obstetrics Department, Coimbra Hospital and University Center, Praceta Professor Mota Pinto, 3000-075 Coimbra, Portugal
2Anatomical Pathology Department, Coimbra Hospital and University Center, Coimbra, Portugal

Received 20 June 2012; Accepted 14 October 2012

Academic Editors: S.-Y. Ku, E. F. C. Murta, and S. Rasmussen

Copyright © 2012 Olga Caramelo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. A. De Fusco, T. A. Gaffey, G. D. Malkasian Jr, H. J. Long, and S. S. Cha, “Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945–1980,” Gynecologic Oncology, vol. 35, no. 1, pp. 8–14, 1989. View at Scopus
  2. K. L. Chang, G. S. Crabtree, S. K. Lim-Tan, R. L. Kempson, and M. R. Hendrickson, “Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases,” American Journal of Surgical Pathology, vol. 14, no. 5, pp. 415–438, 1990. View at Scopus
  3. A. Gadducci, E. Sartori, F. Landoni et al., “Endometrial stromal sarcoma: analysis of treatment failures and survival,” Gynecologic Oncology, vol. 63, no. 2, pp. 247–253, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Amant, I. Vergote, P. Moerman et al., “Response: the classification of a uterine sarcoma as 'High-grade endometrial stromal sarcoma' should be abandoned,” Gynecologic Oncology, vol. 95, no. 2, pp. 412–413, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Moinfar, M. Azodi, and F. A. Tavassoli, “Uterine sarcomas,” Pathology, vol. 39, no. 1, pp. 55–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Yildirim, M. M. Inal, M. Sanci et al., “Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases,” International Journal of Gynecological Cancer, vol. 15, no. 6, pp. 1239–1242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Benoit, L. Arnould, N. Cheynel et al., “Malignant extraovarian endometriosis: a review,” European Journal of Surgical Oncology, vol. 32, no. 1, pp. 6–11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Farquhar, “Extracts from “Clinical Evidence”: endometriosis,” British Medical Journal, vol. 320, no. 7247, pp. 1449–1452, 2000. View at Scopus
  9. S. E. Bulun, “Endometriosis,” New England Journal of Medicine, vol. 360, no. 3, pp. 268–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. L. C. Giudice and L. C. Kao, “Endometriosis,” The Lancet, vol. 364, no. 9447, pp. 1789–1799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. L. A. Brinton, E. J. Lamb, K. S. Moghissi et al., “Ovarian cancer risk associated with varying causes of infertility,” Fertility and Sterility, vol. 82, no. 2, pp. 405–414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Borgfeldt and E. Andolf, “Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis,” Acta Obstetricia et Gynecologica Scandinavica, vol. 83, no. 4, pp. 395–400, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Kobayashi, “Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis,” International Journal of Clinical Oncology, vol. 14, no. 5, pp. 378–382, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Nezhat, M. S. Datta, V. Hanson, T. Pejovic, C. Nezhat, and C. Nezhat, “The relationship of endometriosis and ovarian malignancy: a review,” Fertility and Sterility, vol. 90, no. 5, pp. 1559–1570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Fritel, “Endometriosis anatomoclinical entities,” Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol. 36, no. 2, pp. 113–118, 2007. View at Scopus
  16. M. Eržen, S. Rakar, B. Klančar, and K. Syrjänen, “Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study,” Gynecologic Oncology, vol. 83, no. 1, pp. 100–108, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Van Gorp, F. Amant, P. Neven, I. Vergote, and P. Moerman, “Endometriosis and the development of malignant tumours of the pelvis. A review of literature,” Best Practice and Research, vol. 18, no. 2, pp. 349–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mandai, K. Yamaguchi, N. Matsumura, T. Baba, and I. Konishi, “Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management,” International Journal of Clinical Oncology, vol. 14, no. 5, pp. 383–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Pink, T. Lindner, A. Mrozek et al., “Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature,” Gynecologic Oncology, vol. 101, no. 3, pp. 464–469, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Burke and K. Hickey, “Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue.,” Obstetrics and gynecology, vol. 104, no. 5, pp. 1182–1184, 2004. View at Scopus
  21. M. C. Chu, G. Mor, C. Lim, W. Zheng, V. Parkash, and P. E. Schwartz, “Low-grade endometrial stromal sarcoma: hormonal aspects,” Gynecologic Oncology, vol. 90, no. 1, pp. 170–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. O. Reich, S. Regauer, W. Urdl, M. Lahousen, and R. Winter, “Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas,” British Journal of Cancer, vol. 82, no. 5, pp. 1030–1034, 2000. View at Scopus
  23. A. Garrett and M. A. Quinn, “Hormonal therapies and gynaecological cancers,” Best Practice and Research in Clinical Obstetrics and Gynaecology, vol. 22, no. 2, pp. 407–421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. W. G. McCluggage, “Immunohistochemistry as a diagnostic aid in cervical pathology,” Pathology, vol. 39, no. 1, pp. 97–111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. Li, R. L. Giuntoli, R. Drake et al., “Ovarian preservation in stage I low-grade endometrial stromal sarcomas,” Obstetrics and Gynecology, vol. 106, no. 6, pp. 1304–1308, 2005. View at Scopus
  26. A. Berchuck, S. C. Rubin, W. J. Hoskins, P. E. Saigo, V. K. Pierce, and J. L. Lewis Jr, “Treatment of endometrial stromal tumors,” Gynecologic Oncology, vol. 36, no. 1, pp. 60–65, 1990. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Riopel, M. Plante, M. C. Renaud, M. Roy, and B. Têtu, “Lymph node metastases in low-grade endometrial stromal sarcoma,” Gynecologic Oncology, vol. 96, no. 2, pp. 402–406, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Reich, R. Winter, S. Regauer et al., “Should lymphadenectomy be performed in patients with endometrial stromal sarcoma? [2] (multiple letters),” Gynecologic Oncology, vol. 97, no. 3, pp. 982–983, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Gadducci, S. Cosio, A. Romanini, and A. R. Genazzani, “The management of patients with uterine sarcoma: a debated clinical challenge,” Critical Reviews in Oncology/Hematology, vol. 65, no. 2, pp. 129–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Leunen, M. Breugelmans, P. De Sutter, C. Bourgain, and J. J. Amy, “Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole,” Gynecologic Oncology, vol. 95, no. 3, pp. 769–771, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. K. E. Dusenbery, R. A. Potish, and P. Judson, “Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus,” Gynecologic Oncology, vol. 94, no. 1, pp. 191–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Schilder, W. W. Hurd, L. M. Roth, and G. P. Sutton, “Hormonal treatment of an endometrial stromal nodule followed by local excision,” Obstetrics and Gynecology, vol. 93, no. 5, pp. 805–807, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. P. S. Fekete and F. Vellios, “The clinical and histologic spectrum of endometrial stromal neoplasms: a report of 41 cases,” International Journal of Gynecological Pathology, vol. 3, no. 2, pp. 198–212, 1984. View at Scopus
  34. L. Livi, F. Paiar, N. Shah et al., “Uterine sarcoma: twenty-seven years of experience,” International Journal of Radiation Oncology Biology Physics, vol. 57, no. 5, pp. 1366–1373, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Inayama, A. Shoji, S. Odagiri et al., “Detection of pulmonary metastasis of low-grade endometrial stromal sarcoma 25 years after hysterectomy,” Pathology Research and Practice, vol. 196, no. 2, pp. 129–134, 2000. View at Scopus
  36. K. Bodner, B. Bodner-Adler, A. Obermair et al., “Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients,” Gynecologic Oncology, vol. 81, no. 2, pp. 160–165, 2001. View at Publisher · View at Google Scholar · View at Scopus